The Latest Breaking News from FDA

Exact Sciences Corp. (NYSE:EXAS) on Thursday reported a second-quarter 2025 EPS loss of 1 cent, up from a 9-cent loss a year ago, beating the analyst consensus loss estimate of 19 cents.

The “all-natural” label on a snack food is a powerful marketing tool that can make you feel good about your purchase. However, because the FDA does not regulate the term, food companies can use it on products that contain highly processed and artificial ingredients. One of the most striking examples…

Longer, darker lashes are having a moment. For those avoiding the risk or expense of lash extensions, serums can seem like a safer, more affordable option. But not all lash serums are created equal – and some come with hidden side-effects.

Intelligent Bio Solutions Inc. (NASDAQ:INBS) reported preliminary fiscal fourth quarter revenue results and selected operational highlights on Thursday.

Store brands have exploded in popularity over the last decade. They often promise the same quality as name brands at a lower cost—and sometimes, they even outsell their more expensive counterparts. But when it comes to safety, not all store brands are created equal. In fact, there have been several…

IN FULL

The U.S. Food and Drug Administration has suggested classifying an addictive kratom offshoot as an illicit substance

U.S. health officials have issued warnings on two separate Boston Scientific heart devices recently linked to injuries and deaths

It all started with a RFK Jr. tweet.

Scoring a great deal on vitamins online feels like a win—until it lands your name on a health fraud watchlist. Behind that colorful label and suspiciously low price could be a product flagged by federal agencies. Health authorities, including the FDA and FTC, monitor supplement sales closely, especially those peddled…

The NFL has banned smelling salts from all games starting in 2025, citing FDA warnings about safety concerns and the substances' potential to mask concussion symptoms, leaving players like George Kittle threatening retirement over the controversial decision.